Research models and mesenchymal/epithelial plasticity of osteosarcoma
Abstract Most osteosarcomas (OSs) develop from mesenchymal cells at the bone with abnormal growth in young patients. OS has an annual incidence of 3.4 per million people and a 60–70% 5-year surviving rate. About 20% of OS patients have metastasis at diagnosis, and only 27% of patients with metastati...
Main Authors: | Xiaobin Yu, Jason T. Yustein, Jianming Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Cell & Bioscience |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13578-021-00600-w |
Similar Items
-
Prognostic Role of Epithelial Mesenchymal Transition Transcription Factors in Carcinoma- A Systematic Review and Meta-Analysis
by: Vidyalakshmi Subramanian, et al.
Published: (2021-04-01) -
Oxidized low density lipoprotein receptor 1 promotes lung metastases of osteosarcomas through regulating the epithelial-mesenchymal transition
by: Long Jiang, et al.
Published: (2019-11-01) -
Downregulation of miR-22 Contributes to Epithelial-Mesenchymal Transition in Osteosarcoma by Targeting Twist1
by: Shu-tao Zhu, et al.
Published: (2020-04-01) -
Notch Signaling Pathway Regulates Epithelial-mesenchymal Transition of Osteosarcoma by Activating Slug
by: CHEN Jingteng, et al.
Published: (2020-01-01) -
Comparative Study of Transcriptomics-Based Scoring Metrics for the Epithelial-Hybrid-Mesenchymal Spectrum
by: Priyanka Chakraborty, et al.
Published: (2020-03-01)